Volume pricing
| Quantity | Per vial | Save |
|---|---|---|
| 1–4 | 331.50 USDT | — |
| 5–9 | 315.00 USDT | 5% |
| 10–24 | 291.50 USDT | 12% |
| 25–49 | 271.50 USDT | 18% |
| 50+ | 248.50 USDT | 25% |
FOXO4 DRI
For Research Use Only · Not for Human Consumption
Longevity
FOXO4-DRI is a D-amino-acid retro-inverso peptide designed to disrupt the FOXO4–p53 interaction in senescent cells. It is used in in-vitro and murine senolytic-biology research. Supplied as lyophilized powder at ≥98% HPLC purity. For Research Use Only. Not for Human Consumption. Not a drug, food, or cosmetic.
Potential benefits — preclinical research
- •Senolytic FOXO4-p53 disrupter — selectively eliminates senescent cells in vitro.
- •Improves fitness, fur density and renal function in aged-mouse studies.
- •Reduces SASP (senescence-associated secretory phenotype) markers.
Findings reported in published in-vitro / animal studies. Not therapeutic claims — for research use only.
Certificate of Analysis
View certificate⏱Ships within 15 days — made to order
331.50 USDTper vial
≈ €304.98